486
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Standard intracranial in vivo animal models of delayed cerebral vasospasm

, &
Pages 415-434 | Received 17 Jun 2009, Accepted 02 Mar 2010, Published online: 20 Aug 2010

References

  • Kassell NF, Torner JC, Haley EC, Jr., Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990;73:18–36.
  • Zubkov AY, Nanda A, Zhang JH. Signal transduction pathways in cerebral vasospasm. Pathophysiology 2003;9:47–61.
  • Megyesi JF, Vollrath B, Cook DA, Findlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 2000;46:448–60; discussion 60–1.
  • Kamii H, Kato I, Kinouchi H, Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 1999;30:867–71; discussion 72.
  • McGirt MJ, Parra A, Sheng H, Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002;33:2317–23.
  • Lin CL, Calisaneller T, Ukita N, Dumont AS, Kassell NF, Lee KS. A murine model of subarachnoid hemorrhage-induced cerebral vasospasm. J Neurosci Methods 2003;123:89–97.
  • Rickels E, Zumkeller M. Vasospasm after experimentally induced subarachnoid haemorrhage and treatment with nimodipine. Neurochirurgia (Stuttg) 1992;35:99–102.
  • Solomon RA, Antunes JL, Chen RY, Bland L, Chien S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke 1985;16:58–64.
  • Svendgaard NA, Brismar J, Delgado TJ, Rosengren E. Subarachnoid haemorrhage in the rat: effect on the development of vasospasm of selective lesions of the catecholamine systems in the lower brain stem. Stroke 1985;16:602–8.
  • Nikaido H, Tsunoda H, Nishimura Y, Kirino T, Tanaka T. Potential role for heat shock protein 72 in antagonizing cerebral vasospasm after rat subarachnoid hemorrhage. Circulation 2004;110:1839–46.
  • Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003;52:165–75; discussion 75–6.
  • Vikman P, Beg S, Khurana T, Hansen-Schwartz J, Edvinsson L. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 2006;105:438–44.
  • Lin CL, Kwan AL, Dumont AS, Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303. J Neurosurg 2007;106:442–8.
  • Satoh M, Date I, Ohmoto T, Perkins E, Parent AD. The expression and activation of matrix metalloproteinase-1 after subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 2005;147:187–92; discussion 92–3.
  • Longo M, Blandino A, Ascenti G, Ricciardi GK, Granata F, Vinci S. Cerebral angiography in the rat with mammographic equipment: a simple, cost-effective method for assessing vasospasm in experimental subarachnoid haemorrhage. Neuroradiology 2002;44:689–94.
  • Yamamoto S, Nishizawa S, Yokoyama T, Ryu H, Uemura K. Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries. Brain Res 1997;757:1–9.
  • Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991;22:922–7.
  • Swift DM, Solomon RA. Subarachnoid hemorrhage fails to produce vasculopathy or chronic blood flow changes in rats. Stroke 1988;19:878–82.
  • Nakagomi T, Kassell NF, Johshita H, Lehman RM, Fujiwara S, Sasaki T. Blood-arterial wall barrier disruption to various sized tracers following subarachnoid haemorrhage. Acta Neurochir (Wien) 1989;99:76–84.
  • Lin CL, Su YF, Dumont AS, The effect of an adenosine A1 receptor agonist in the treatment of experimental subarachnoid hemorrhage-induced cerebrovasospasm. Acta Neurochir (Wien) 2006;148:873–9; discussion 9.
  • Kemaloglu S, Ozkan U, Yilmaz F, Preventive effects of intracisternal alphatochopherol on cerebral vasospasm in experimental subarachnoid haemorrhage. Yonsei Med J 2003;44:955–60.
  • Vatter H, Weidauer S, Konczalla J, Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 2006;58:1190–7; discussion -7.
  • Barry KJ, Gogjian MA, Stein BM. Small animal model for investigation of subarachnoid hemorrhage and cerebral vasospasm. Stroke 1979;10:538–41.
  • Delgado TJ, Arbab MA, Diemer NH, Svendgaard NA. Subarachnoid hemorrhage in the rat: cerebral blood flow and glucose metabolism during the late phase of cerebral vasospasm. J Cereb Blood Flow Metab 1986;6:590–9.
  • Delgado TJ, Arbab MA, Warberg J, Svendgaard NA. The role of vasopressin in acute cerebral vasospasm. Effect on spasm of a vasopressin antagonist or vasopressin antiserum. J Neurosurg 1988;68:266–73.
  • Verlooy J, Van Reempts J, Haseldonckx M, Borgers M, Selosse P. The course of vasospasm following subarachnoid haemorrhage in rats. A vertebrobasilar angiographic study. Acta Neurochir (Wien) 1992;117:48–52.
  • Suzuki H, Kanamaru K, Tsunoda H, Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 1999;104:59–66.
  • Ono S, Date I, Onoda K, Ohmoto T. Time course of the diameter of the major cerebral arteries after subarachnoid hemorrhage using corrosion cast technique. Neurol Res 2003;25:383–9.
  • Trandafir CC, Nishihashi T, Wang A, Murakami S, Ji X, Kurahashi K. Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 2004;31:261–6.
  • Meguro T, Clower BR, Carpenter R, Parent AD, Zhang JH. Improved rat model for cerebral vasospasm studies. Neurol Res 2001;23:761–6.
  • Miyagi Y, Carpenter RC, Meguro T, Parent AD, Zhang JH. Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg 2000;93:471–6.
  • Tuncer R. Experimental basilar artery spasm caused by autologous blood application: effects of clot removal and topical nicardipine. Acta Neurochir (Wien) 1993;121:72–5.
  • Yanamoto H, Kikuchi H, Okamoto S, Nozaki K. Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits. Neurosurgery 1992;30:351–6; discussion 6–7.
  • McGirt MJ, Pradilla G, Legnani FG, Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 2006;58:945–51; discussion -51.
  • Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke 2002;33:2681–6.
  • German JW, Gross CE, Giclas P, Watral W, Bednar MM. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 1996;39:141–5; discussion 5–6.
  • Shishido T, Suzuki R, Qian L, Hirakawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke 1994;25:864–8.
  • Roux S, Loffler BM, Gray GA, Sprecher U, Clozel M, Clozel JP. The role of endothelin in experimental cerebral vasospasm. Neurosurgery 1995;37:78–85; discussion -6.
  • Vollmer DG, Kassell NF, Hongo K, Ogawa H, Tsukahara T. Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm. Surg Neurol 1989;31:190–4.
  • Pasqualin A, Vollmer DG, Marron JA, Tsukahara T, Kassell NF, Torner JC. The effect of nicardipine on vasospasm in rabbit basilar artery after subarachnoid hemorrhage. Neurosurgery 1991;29:183–8.
  • Hirashima Y, Endo S, Kato R, Takaku A. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. J Neurosurg 1996;84:826–30.
  • Sonmez OF, Unal B, Inaloz S, Therapeutic effects of intracarotid infusion of spermine/nitric oxide complex on cerebral vasospasm. Acta Neurochir (Wien) 2002;144:921–8; discussion 8.
  • Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 1996;84:503–7.
  • Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003;34:434–40.
  • Zuccarello M, Marsch JT, Schmitt G, Woodward J, Anderson DK. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:98–104.
  • Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 1984;61:1120–8.
  • Nakagomi T, Kassell NF, Hongo K, Sasaki T. Pharmacological reversibility of experimental cerebral vasospasm. Neurosurgery 1990;27:582–6.
  • Vorkapic P, Bevan JA, Bevan RD. Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery. Neurosurg Rev 1991;14:215–9.
  • Ahmad I, Imaizumi S, Shimizu H, Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 1996;138:1230–40.
  • Johshita H, Kassell NF, Sasaki T, Nakagomi T, Ogawa H. Biphasic constriction of rabbit basilar artery following experimental subarachnoid hemorrhage: a morphometric study. Surg Neurol 1992;37:106–14.
  • Fadel MM, Foley PL, Kassell NF, Lee KS. Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg Neurol 1995;43:52–7; discussion 7–8.
  • Zhou ML, Shi JX, Zhu JQ, Comparison between one- and two-hemorrhage models of cerebral vasospasm in rabbits. J Neurosci Meth 2007;159:318–24.
  • Nakajima M, Date I, Takahashi K, Ninomiya Y, Asari S, Ohmoto T. Effects of aging on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 2001;32:620–8.
  • Kaminuma T, Shimizu H, Ahmad I, Prevention of cerebral vasospasm by vasodilatory peptide maxadilan following subarachnoid hemorrhage in rabbits. J Control Release 1998;52:71–80.
  • Yanamoto H, Kikuchi H, Okamoto S. Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Surg Neurol 1994;42:382–7.
  • Vorkapic P, Bevan JA, Bevan RD. Clentiazem protects against chronic cerebral vasospasm in rabbit basilar artery. Stroke 1991;22:1409–13.
  • Spallone A, Pastore FS. Cerebral vasospasm in a double-injection model in rabbit. Surg Neurol 1989;32:408–17.
  • Edvinsson L, Egund N, Owman C, Sahlin C, Svendgaard NA. Reduced noradrenaline uptake and retention in cerebrovascular nerves associated with angiographically visible vasoconstriction following experimental subarachnoid hemorrhage in rabbits. Brain Res Bull 1982;9:799–805.
  • Nomura H, Hirashima Y, Endo S, Takaku A. Anticardiolipin antibody aggravates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 1998;29:1014–8; discussion 8–9.
  • Endo S, Branson PJ, Alksne JF. Experimental model of symptomatic vasospasm in rabbits. Stroke 1988;19:1420–5.
  • Baker KF, Zervas NT, Pile-Spellman J, Vacanti FX, Miller D. Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm. Surg Neurol 1987;27:107–12.
  • Hacein-Bey L, Harder DR, Meier HT, Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage. AJNR Am J Neuroradiol 2006;27:1350–4.
  • Bulsara KR, Coates JR, Agrawal VK, Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model. Neurosurg Focus 2006;21:E11.
  • Alexander E, 3rd, Black PM, Liszczak TM, Zervas NT. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH. J Neurosurg 1985;63:949–58.
  • Harder DR, Dernbach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 1987;80:875–80.
  • Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989;20:1021–6.
  • Kim P, Sundt TM, Jr., Vanhoutte PM. Alterations in endothelium-dependent responsiveness of the canine basilar artery subarachnoid hemorrhage. J Neurosurg 1988;69:239–46.
  • Kim P, Lorenz RR, Sundt TM, Jr., Vanhoutte PM. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg 1989;70:108–14.
  • Kim P, Sundt TM, Jr., Vanhoutte PM. Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage. J Neurosurg 1989;71:430–6.
  • Kim P, Schini VB, Sundt TM, Jr., Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992;70:248–56.
  • Vollrath B, Chan P, Findlay M, Cook D. Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle. Cardiovasc Res 1995;30:619–26.
  • Saito A, Nakazawa T. Cerebral vasospasm model produced by subarachnoid blood injection in dogs. Jpn J Pharmacol 1989;50:250–2.
  • Yoshimoto Y, Kim P, Sasaki T, Takakura K. Temporal profile and significance of metabolic failure and trophic changes in the canine cerebral arteries during chronic vasospasm after subarachnoid hemorrhage. J Neurosurg 1993;78:807–12.
  • Kim P, Yoshimoto Y, Nakaguchi H, Increased sarcolemmal permeability in the cerebral artery during chronic spasm: an assessment using DNA-binding dyes and detection of apoptosis. J Cereb Blood Flow Metab 1999;19:889–97.
  • Nozaki K, Uemura Y, Okamoto S, Kikuchi H, Mizuno N. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs. J Neurosurg 1989;71:558–64.
  • Liu B, Wang C, Wu J, Wu Z, Sun Y. Azathioprine and methylprednisolone: prevention of chronic cerebral vasospasm in dogs. Chin Med J (Engl) 2000;113:720–4.
  • Zhou C, Yamaguchi M, Colohan AR, Zhang JH. Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005;25:572–82.
  • Foley PL, Kassell NF, Hudson SB, Lee KS. Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection. Acta Neurochir (Wien) 1993;123:82–6.
  • Kim I, Leinweber BD, Morgalla M, Thin and thick filament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 2000;46:440–6; discussion 6–7.
  • Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 2001;32:636–42.
  • Yamada T, Tanaka Y, Fujimoto K, Nakahara N, Matsui T, Shinoda S, Masuzawa T. Relationship between cytosolic Ca2+ level and contractile tension in canine basilar artery of chronic vasospasm. Neurosurgery 1994;34:496–503; discussion -4.
  • Todo H, Ohta S, Wang J, Impairment in biochemical level of arterial dilative capability of a cyclic nucleotides-dependent pathway by induced vasospasm in the canine basilar artery. J Cereb Blood Flow Metab 1998;18:808–17.
  • Diringer MN, Heffez DS, Monsein L, Kirsch JR, Hanley DF, Traystman RJ. Cerebrovascular CO2 reactivity during delayed vasospasm in a canine model of subarachnoid hemorrhage. Stroke 1991;22:367–72.
  • Zabramski J, Spetzler RF, Bonstelle C. Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery 1986;18:129–35.
  • Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004;24:419–31.
  • Nishizawa S, Chen D, Yokoyama T, Yokota N, Otha S. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm. Acta Neurochir (Wien) 2000;142:1409–15.
  • Macdonald RL, Zhang J, Sima B, Johns L. Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs. Neurosurgery 1995;37:962–7; discussion 7–8.
  • Nozaki K, Okamoto S, Yanamoto H, Kikuchi H. Red blood cells are essential for late vasospasm following experimentally induced subarachnoid hemorrhage in dogs. Neurol Med Chir (Tokyo) 1990;30:10–5.
  • Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000;87:195–200.
  • Mima T, Mostafa MG, Mori K. Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl 1997;70:65–7.
  • Yin W, Tibbs R, Aoki K, Badr A, Zhang J. Metabolic alterations in cerebrospinal fluid from double hemorrhage model of dogs. Neurol Res 2001;23:87–92.
  • Yamakawa K, Sasaki T, Tsubaki S, Nakagomi T, Saito I, Takakura K. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1991;31:24–31.
  • Ohta S, Nishihara J, Oka Y, Todo H, Kumon Y, Sakaki S. Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage. Acta Neurochir (Wien) 1995;137:217–25.
  • Shigeno T, Clozel M, Sakai S, Saito A, Goto K. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 1995;37:87–90 discussion -1.
  • Nishizawa S, Yamamoto S, Yokoyama T, Ryu H, Uemura K. Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm. Stroke 1995;26:1916–20 discussion 20–1.
  • Oka Y, Ohta S, Todo H, Kohno K, Kumon Y, Sakaki S. Protein synthesis and immunoreactivities of contraction-related proteins in smooth muscle cells of canine basilar artery after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 1996;16:1335–44.
  • Sun H, Kanamaru K, Ito M, Myosin light chain phosphorylation and contractile proteins in a canine two-hemorrhage model of subarachnoid hemorrhage. Stroke 1998;29:2149–54.
  • Macdonald RL, Zhang ZD, Takahashi M, Calcium sensitivity of vasospastic basilar artery after experimental subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 2006;290: H2329–36.
  • Yamaguchi-Okada M, Nishizawa S, Koide M, Nonaka Y. Biomechanical and phenotypic changes in the vasospastic canine basilar artery after subarachnoid hemorrhage. J Appl Physiol 2005;99:2045–52.
  • Sakaki S, Ohue S, Kohno K, Takeda S. Impairement of vascular reactivity and changes in intracellular calcium and calmodulin levels of smooth muscle cells in canine basilar arteries after subarachnoid hemorrhage. Neurosurgery 1989;25:753–61.
  • Macdonald RL, Marton LS, Andrus PK, Hall ED, Johns L, Sajdak M. Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs. Life Sci 2004;75:979–89.
  • Peterson JW, Nishizawa S, Hackett JD, Bun T, Teramura A, Zervas NT. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 1990;21:133–7.
  • Watanabe T, Asano T, Shimizu T, Seyama Y, Takakura K. Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem 1988;50:1145–50.
  • Ohkuma H, Tsurutani H, Suzuki S. Changes of beta-actin mRNA expression in canine vasospastic basilar artery after experimental subarachnoid hemorrhage. Neurosci Lett 2001;311:9–12.
  • Kasuya H, Kawashima A, Sasahara A, Onda H, Hori T. Development of nicardipine prolonged-release implants for preventing vasospasm. Acta Neurochir Suppl 2001;77:217–20.
  • Aihara Y, Kasuya H, Onda H, Hori T, Takeda J. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 2001;32:212–7.
  • Yin W, Tibbs R, Tang J, Badr A, Zhang J. Haemoglobin and ATP levels in CSF from a dog model of vasospasm. J Clin Neurosci 2002;9:425–8.
  • Noseworthy TW, Weir B, Boisvert D, Espinosa F, Overton T, Marshal ML. Effect of reserpine-kanamycin treatment on chronic vasospasm after platelet-enriched subarachnoid hemorrhage in primates. Neurosurgery 1984;14:193–7.
  • Inoue T, Shimizu H, Kaminuma T, Tajima M, Watabe K, Yoshimoto T. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Neurosurgery 1996;39:984–90.
  • Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T. Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage. Neurol Res 1998;20:625–31.
  • Clatterbuck RE, Gailloud P, Ogata L, Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 2003;99: 376–82.
  • Pluta RM, Deka-Starosta A, Zauner A, Morgan JK, Muraszko KM, Oldfield EH. Neuropeptide Y in the primate model of subarachnoid hemorrhage. J Neurosurg 1992;77:417–23.
  • Nakao K, Murata H, Kanamaru K, Waga S. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage. Stroke 1996;27:1882–7; discussion 7–8.
  • Findlay JM, Macdonald RL, Weir BK, Grace MG. Surgical manipulation of primate cerebral arteries in established vasospasm. J Neurosurg 1991;75:425–32.
  • Findlay JM, Weir BK, Gordon P, Grace M, Baughman R. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 1989;24:491–8.
  • Findlay JM, Weir BK, Steinke D, Tanabe T, Gordon P, Grace M. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 1988;69:723–35.
  • Kanamaru K, Weir BK, Findlay JM, Krueger CA, Cook DA. Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J Neurosurg 1989;71:909–15.
  • Macdonald RL, Weir BK, Young JD, Grace MG. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys. J Neurosurg 1992; 76: 81–90.
  • Lewis PJ, Weir BK, Nosko MG, Tanabe T, Grace MG. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 1988;22:492–500.
  • Findlay JM, Weir BK, Kanamaru K, Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature. Can J Neurol Sci 1989;16:28–40.
  • Findlay JM, Weir BK, Kanamaru K, Grace M, Baughman R. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 1990;26:201–6.
  • Kanamaru K, Weir BK, Findlay JM, Grace M, Macdonald RL. A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model. Neurosurgery 1990;27:29–38.
  • Kanamaru K, Weir BK, Simpson I, Witbeck T, Grace M. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 1991;74:454–9.
  • Pluta RM, Zauner A, Morgan JK, Muraszko KM, Oldfield EH. Is vasospasm related to proliferative arteriopathy? J Neurosurg 1992;77:740–8.
  • Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 2004;101:836–42.
  • Espinosa F, Weir B, Shnitka T. Electron microscopy of simian cerebral arteries after subarachnoid hemorrhage and after the injection of horseradish peroxidase. Neurosurgery 1986;19:935–45.
  • Handa Y, Hayashi M, Takeuchi H, Kobayashi H, Kawano H, Kabuto M. Effect of cyclosporine on the development of cerebral vasospasm in a primate model. Neurosurgery 1991;28:380–5; discussion 5–6.
  • Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991;28:542–9.
  • Nosko M, Weir B, Krueger C, Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Neurosurgery 1985;16:129–36.
  • Krueger C, Weir B, Nosko M, Cook D, Norris S. Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm. Neurosurgery 1985;16:137–40.
  • Hara H, Edvinsson L. Perivascular innervation of the cerebral circulation: involvement in the pathophysiology of subarachnoid hemorrhage. Neurosurg Rev 1987;10:171–9.
  • Nosko M, Norris SL, Weir B, King EG, Grace M. Nimodipine and chronic vasospasm in monkeys: Part 3. Cardiopulmonary effects. Neurosurgery 1986;18:261–5.
  • Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg 1984;60:1167–75.
  • Espinosa F, Weir B, Shnitka T, Overton T, Boisvert D. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings. J Neurosurg 1984;60:1176–85.
  • Kobayashi H, Ide H, Aradachi H, Arai Y, Handa Y, Kubota T. Histological studies of intracranial vessels in primates following transluminal angioplasty for vasospasm. J Neurosurg 1993;78:481–6.
  • Ono S, Zhang ZD, Marton LS, Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 2000;20:1066–76.
  • Stoodley M, MacDonald RL, Weir B, Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries. J Neurosurg 2000;93:463–70.
  • Macdonald RL, Zhang ZD, Curry D, Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery 2002;51:761–8; discussion 8–70.
  • Zhang ZD, Yamini B, Komuro T, Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke 2001;32:1868–74.
  • Handa Y, Hayashi M, Takeuchi H, Kubota T, Kobayashi H, Kawano H. Time course of the impairment of cerebral autoregulation during chronic cerebral vasospasm after subarachnoid hemorrhage in primates. J Neurosurg 1992;76:493–501.
  • Handa Y, Kaneko M, Matuda T, Kobayashi H, Kubota T. In vivo proton magnetic resonance spectroscopy for metabolic changes in brain during chronic cerebral vasospasm in primates. Neurosurgery 1997;40:773–80; discussion 80–1.
  • Zhang ZD, Yamini B, Komuro T, Delayed clot removal and experimental vasospasm. Acta Neurochir Suppl 2001;77:33–5.
  • Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jama 2005;293:1477–84.
  • Pluta RM, Jung CS, Harvey-White J, In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates. J Neurosurg 2005;103:731–8.
  • Macdonald RL, Zhang ZD, Ono S, Komuro T. Up-regulation of parathyroid hormone receptor in cerebral arteries after subarachnoid hemorrhage in monkeys. Neurosurgery 2002;50:1083–91; discussion 91–3.
  • Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res 2002;24:510–6.
  • Saito A, Kamii H, Kato I, Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental subarachnoid hemorrhage. Stroke 2001;32:1652–7.
  • Mesis RG, Wang H, Lombard FW, Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 2006;21:E4.
  • Gao J, Wang H, Sheng H, A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 2006;4:25–31.
  • Alkan T, Korfali E, Kahveci N. Experimental subarachnoid haemorrhage models in rats. Acta Neurochir Suppl 2002;83:61–9.
  • Kader A, Krauss WE, Onesti ST, Elliott JP, Solomon RA. Chronic cerebral blood flow changes following experimental subarachnoid hemorrhage in rats. Stroke 1990;21:577–81.
  • Tureyen K, Nazlioglu HO, Alkan T, Kahveci N, Korfali E. Single or multiple small subarachnoid hemorrhages by puncturing a small branch of the rat basilar artery causes chronic cerebral vasospasm. Neurosurgery 2005;56:382–90; discussion –90.
  • Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985;16:595–602.
  • Clower BR, Yoshioka J, Honma Y, Smith RR. Pathological changes in cerebral arteries following experimental subarachnoid hemorrhage: role of blood platelets. Anat Rec 1988;220:161–70.
  • Gules I, Satoh M, Clower BR, Nanda A, Zhang JH. Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol 2002;283:H2551–9.
  • Turowski B, Hanggi D, Beck A, Aurich V, Steiger HJ, Moedder U. New angiographic measurement tool for analysis of small cerebral vessels: application to a subarachnoid haemorrhage model in the rat. Neuroradiology 2007;49:129–37.
  • Ono S, Date I, Nakajima M, Three-dimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique. Stroke 1997;28:1631–7; discussion 8.
  • Vatter H, Weidauer S, Dias S, Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage. Neurosurgery 2007;60:179–87; discussion 87–8.
  • Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17:472–6.
  • Liszczak TM, Black PM, Tzouras A, Foley L, Zervas NT. Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental SAH. J Neurosurg 1984;61:486–93.
  • Zuccarello M, Boccaletti R, Romano A, Rapoport RM. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 1998;29:1924–9.
  • Kuwayama A, Zervas NT, Belson R, Shintani A, Pickren K. A model for experimental cerebral arterial spasm. Stroke 1972;3:49–56.
  • Varsos VG, Liszczak TM, Han DH, Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a “two-hemorrhage” canine model. J Neurosurg 1983;58:11–7.
  • Zabramski JM, Spetzler RF, Bonstelle C. Chronic cerebral vasospasm: effect of volume and timing of hemorrhage in a canine model. Neurosurgery 1986;18:1–6.
  • Mori T, Asano T, Nagata K, Ishida T, Abe T. An improved canine model of subarachnoid hemorrhage using intrathecal indwelling catheters. J Vet Med Sci 1997;59:825–8.
  • Mizuno T, Hamada J, Kai Y, Todaka T, Morioka M, Ushio Y. Single blood injection into the ventral cisterna magna through a microcatheter for the production of delayed cerebral vasospasm: experimental study in dogs. AJNR Am J Neuroradiol 2003;24:608–12.
  • White RP, Hagen AA, Robertson JT. Effect of nonsteroid anti-inflammatory drugs on subarachnoid hemorrhage in dogs. J Neurosurg 1979;51:164–71.
  • Tibbs R, Zubkov A, Aoki K, Effects of mitogen-activated protein kinase inhibitors on cerebral vasospasm in a double-hemorrhage model in dogs. J Neurosurg 2000;93:1041–7.
  • Kusaka G, Kimura H, Kusaka I, Perkins E, Nanda A, Zhang JH. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2003;99:383–90.
  • Yamaguchi M, Zhou C, Nanda A, Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 2004;35:1750–5.
  • Yatsushige H, Yamaguchi M, Zhou C, Calvert JW, Zhang JH. Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2005;36:1538–43.
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–4.
  • Chow RW, Newton TH, Smith MC, Adams JE. Cerebral vasospasm induced by subarachnoid blood and serotonin. An angiographic study. Invest Radiol 1968;3:402–7.
  • Landau B, Ransohoff J. Prolonged cerebral vasospasm in experimental subarachnoid hemorrhage. Neurology 1968;18:1056–65.
  • Weir B, Erasmo R, Miller J, McIntyre J, Secord D, Mielke B. Vasospasm in response to repeated subarachnoid hemorrhages in the monkey. J Neurosurg 1970;33:395–406.
  • Echlin F. Experimental vasospasm, acute and chronic, due to blood in the subarachnoid space. J Neurosurg 1971;35:646–56.
  • Sahlin C, Brismar J, Delgado T, Owman C, Salford LG, Svendgaard NA. Cerebrovascular and metabolic changes during the delayed vasospasm following experimental subarachnoid hemorrhage in baboons, and treatment with a calcium antagonist. Brain Res 1987;403:313–32.
  • Delgado-Zygmunt TJ, Arbab MA, Shiokawa Y, Svendgaard NA. A primate model for acute and late cerebral vasospasm: angiographic findings. Acta Neurochir (Wien) 1992;118:130–6.
  • Davis JM, Davis KR, Crowell RM. Subarachnoid hemorrhage secondary to ruptured intracranial aneurysm: prognostic significance of cranial CT. AJR Am J Roentgenol 1980;134:711–5.
  • Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9.
  • Espinosa F, Weir B, Boisvert D, Overton T, Castor W. Chronic cerebral vasospasm after large subarachnoid hemorrhage in monkeys. J Neurosurg 1982;57:224–32.
  • Clower BR, Smith RR, Haining JL, Lockard J. Constrictive endarteropathy following experimental subarachnoid hemorrhage. Stroke 1981;12:501–8.
  • Jakubowski J, Bell BA, Symon L, Zawirski MB, Francis DM. A primate model of subarachnoid hemorrhage: change in regional cerebral blood flow, autoregulation carbon dioxide reactivity, and central conduction time. Stroke 1982;13:601–11.
  • Frazee JG. A primate model of chronic cerebral vasospasm. Stroke 1982; 13: 612–4.
  • Botterell EH, Lougheed WM, Scott JW, Vandewater SL. Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms. J Neurosurg 1956:13:1–42.
  • Petruk KC, Weir BK, Marriott MR, Overton TR. Clinical grade, egional cerebral blood flow and angiographical spasm in the monkey after subarachnoid and subdural hemorrhage. Stroke 1973;4:431–45.
  • Handa Y, Weir BK, Nosko M, Mosewich R, Tsuji T, Grace M. The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg 1987;67:558–64.
  • Clatterbuck RE, Gailloud P, Tierney T, Clatterbuck VM, Murphy KJ, Tamargo RJ. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 2005;103:745–51.
  • Lacy PS, Earle AM. A small animal model for electrocardiographic abnormalities observed after an experimental subarachnoid hemorrhage. Stroke 1983;14:371–7.
  • Ram Z, Sahar A, Hadani M. Vasospasm due to massive subarachnoid haemorrhage–a rat model. Acta Neurochir (Wien) 1991;110:181–4.
  • Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995;26:1086–91; discussion 91–2.
  • Veelken JA, Laing RJ, Jakubowski J. The Sheffield model of subarachnoid hemorrhage in rats. Stroke 1995;26:1279–83; discussion 84.
  • Piepgras A, Thome C, Schmiedek P. Characterization of an anterior circulation rat subarachnoid hemorrhage model. Stroke 1995;26:2347–52.
  • Medele RJ, Stummer W, Reulen HJ, Steiger HJ. Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm. Neurol Res 1996;18:277–80.
  • Schwartz AY, Masago A, Sehba FA, Bederson JB. Experimental models of subarachnoid hemorrhage in the rat: a refinement of the endovascular filament model. J Neurosci Methods 2000;96:161–7.
  • Ergun R, Fernandez J, Misra M, Dujovny M. Endoscopic technique: a new model of subarachnoid hemorrhage in rats. Neurol Res 2001;23:627–30.
  • Logothetis J, Karacostas D, Karoutas G, Artemis N, Mansouri A, Milonas I. A new model of subarachnoid hemorrhage in experimental animals with the purpose to examine cerebral vasospasm. Exp Neurol 1983;81:257–78.
  • Nelson RJ, Perry S, Hames TK, Pickard JD. Transcranial Doppler ultrasound studies of cerebral autoregulation and subarachnoid hemorrhage in the rabbit. J Neurosurg 1990;73:601–10.
  • Egemen N, Sanlidilek U, Zorlutuna A, Transclival approach to rabbit basilar artery for experimental induction of chronic vasospasm. Acta Neurochir (Wien) 1992;115:123–6.
  • Foley PL, Caner HH, Kassell NF, Lee KS. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 1994;34:108–12; discussion 12–3.
  • Goksel HM, Akgun M, Topalkara K, Solak O, Topaktas S. Evaluation of cerebral vasospasm with transcranial magnetic stimulation: an experimental study. Clin Exp Med 2001;1:43–9.
  • Lougheed WM, Tom M. A method of introducing blood into the subarachnoid space in the region of the circle of Willis in dogs. Can J Surg 1961;4:329–37.
  • Brawley BW, Strandness DE, Jr., Kelly WA. The biphasic response of cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg 1968;28:1–8.
  • Pennink M, White RP, Crockarell JR, Robertson JT. Role of prostaglandin F 2 in the genesis of experimental cerebral vasospasm. Angiographic study in dogs. J Neurosurg 1972;37:398–406.
  • Nagai H, Suzuki Y, Sugiura M, Noda S, Mabe H. Experimental cerebral vasospasm. 1: Factors contributing to early spasm. J Neurosurg 1974;41:285–92.
  • Steiner L, Lofgren J, Zwetnow NN. Characteristics and limits of tolerance in repeated subarachnoid hemorrhage in dogs. Acta Neurol Scand 1975;52:241–67.
  • Letarte PB, Lieberman K, Nagatani K, Haworth RA, Odell GB, Duff TA. Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cells. J Neurosurg 1993;79:252–5.
  • Echlin FA. Spasm of basilar and vertebral arteries caused by experimental subarachnoid hemorrhage. J Neurosurg 1965;23:1–11.
  • Simeone FA, Ryan KG, Cotter JR. Prolonged experimental cerebral vasospasm. J Neurosurg 1968;29:357–66.
  • Kapp J, Mahaley MS, Jr., Odom GL. Cerebral arterial spasm. 2. Experimental evaluation of mechanical and humoral factors in pathogenesis. J Neurosurg 1968;29:339–49.
  • Yamaguchi T, Waltz AG. Effects of subarachnoid hemorrhage from puncture of the middle cerebral artery on blood flow and vasculature of the cerebral cortex in the cat. J Neurosurg 1971;35:664–71.
  • Hayakawa T, Waltz AG. Experimental subarachnoid hemorrhage from a middle cerebral artery. Neurologic deficits, intracranial pressures, blood pressures, and pulse rates. Stroke 1977;8:421–6.
  • Mayberg MR, Houser OW, Sundt TM, Jr. Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage. J Neurosurg 1978;48:49–57.
  • Trojanowski T. Blood-brain barrier changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 1982;60:45–54.
  • Trojanowski T. Experimental subarachnoid haemorrhage. Part I. a new approach to subarachnoid blood injection in cats. Acta Neurochir (Wien) 1982;62:171–5.
  • Yamamoto Y, Clower BR, Haining JL, Smith RR. Effect of tissue plasminogen activator on intimal platelet accumulation in cerebral arteries after subarachnoid hemorrhage in cats. Stroke 1991;22:780–4.
  • Diringer MN, Kirsch JR, Hanley DF, Traystman RJ. Altered cerebrovascular CO2 reactivity following subarachnoid hemorrhage in cats. J Neurosurg 1993;78:915–21.
  • Takemae T, Branson PJ, Alksne JF. Intimal proliferation of cerebral arteries after subarachnoid blood injection in pigs. J Neurosurg 1984;61:494–500.
  • Mayberg MR, Okada T, Bark DH. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg 1990;72:626–33.
  • Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 1992;76:830–7.
  • Alabadi JA, Salom JB, Torregrosa G, Miranda FJ, Jover T, Alborch E. Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 1993;33:707–14; discussion 14–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.